Carlo Basurto

Central Nervous System Metastases in HER-2–Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors

Stefania Gori, S Rimondini, Verena De Angelis et al. · The Oncologist · 2007 · 146 citations · Full text

Medicine, Oncology, Breast Oncology +16

Predictive Factors of Delayed Emesis in Cisplatin-Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or Dexamethasone

Fausto Roila, Enrico Boschetti, Maurizio Tonato et al. · American Journal of Clinical Oncology · 1991 · 102 citations

Medicine, Pharmacology, Pharmacotherapy +17

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain

Vincenzo Minotti, L. Patoia, Fausto Roila et al. · Pain · 1989 · 52 citations

Nursing, Pharmacology, Pharmacotherapy +16

Antiemetic Activity of High-Dose Metoclopramide Combined with Methylprednisolone Versus Metoclopramide Alone in Dacarbazine-Treated Cancer Patients

Carlo Basurto, Fausto Roila, Maurizio Tonato et al. · American Journal of Clinical Oncology · 1989 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +17